How much funding has Aether Biomachines raised?

Aether Biomachines has raised $49.0M in total funding, most recently a Series A round.

Who are Aether Biomachines's investors?

Aether Biomachines's investors include Tribe Capital, Abstract Ventures.

Where is Aether Biomachines headquartered?

Aether Biomachines is headquartered in San Francisco, California, United States.

What industry is Aether Biomachines in?

Aether Biomachines operates in Artificial Intelligence, Biotech.

How many employees does Aether Biomachines have?

Aether Biomachines has 1-10 employees.

Aether Biomachines

AI-designed molecular machines powering the next industrial revolution

San Francisco, United States · $49.0M raised

Artificial Intelligence

Biotech

Headquarters: San Francisco, California
Employees: 1–10
Business Model: B2B

Total Funding: $49.0M
Last Round: $49.0M Series AAug 2023
Rounds: 1

About

Aether Biomachines is an American artificial intelligence company that discovers and designs proteins with high-impact real-world applications in super materials, critical mineral processing, and advanced manufacturing. At the core of its platform is a Protein Function Model trained on millions of reactions across the full universe of possible chemistry, combined with a proprietary robotic lab that runs massively parallelized experiments to index sequence space at scale. The company's commercial products include the RapidPrint™ and Ultra™ series of reinforced polymer filaments for additive manufacturing, with next-generation super materials and critical mineral separation technologies in development.

Summary

Aether Biomachines is an Artificial Intelligence company based in San Francisco, United States. It has raised $49.0M in total across 1 round, most recently a $49.0M Series A round in Aug 2023. Investors include Tribe Capital and Abstract Ventures.